Use of High-dose Oxazaphosphorine Drugs for Treating Immune Disorders

This disclosure relates, at least in part, to methods of eliminating adverse immune reactions in a subject in need thereof including those associated with autoimmune diseases, allergic reactions and transplant rejection, including administration of a lymphocytotoxic non-myeloablative amount of a oxazaphosphorine drug to the subject.

Patents:
US 20,110,092,462

Inventor(s): BRODSKY ROBERT A [US]; JONES RICHARD J [US]

Type of Offer: Licensing



« More Life Sciences Patents

---